EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum KL-6 and SP-D: Markers of Lung Function in Autoimmune-Related Interstitial Lung Diseases

Ewa Miądlikowska iD, Joanna Miłkowska-Dymanowska iD, Adam Jerzy Białas iD, Joanna Samanta Makowska, Anna Lewandowska-Polak iD, Anna Puła, Anna Kumor-Kisielewska, Wojciech Jerzy Piotrowski iD

International Journal of Molecular Sciences · 27.01.2025 · 26 (3) · 1091

DOI: 10.3390/ijms26031091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.01.2025. Verfasst von Ewa Miądlikowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Medical University of Lodz, 90-419 Lodz, Poland. Hauptthemen laut MEDLINE: Mucin-1, Lung Diseases, Interstitial, Pulmonary Surfactant-Associated Protein D, Lung. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluates the usefulness of serum KL-6, SP-D and TGF-β1 levels in assessing lung impairment and predicting interstitial lung disease (ILD) short-term progression in patients with interstitial pneumonia with autoimmune features (IPAF). A total of 24 patients with IPAF, 21 with connective tissue disease-associated ILD (CTD-ILD) and 23 with CTD without ILD were followed for 1 year. Serum levels of KL-6, SP-D and TGF-β1 were measured and their associations with disease severity and progression were analysed. KL-6, SP-D and TGF-β1 levels were significantly higher in IPAF and CTD-ILD patients compared to CTD without ILD (p < 0.0001, p = 0.0005 and p = 0.0001, respectively). KL-6 (r = 0.45, p = 0.002) and SP-D (r = 0.35, p = 0.02) levels correlated with lung involvement in HRCT in the ILD group. In IPAF, KL-6 levels correlated with pulmonary function tests (FVC%, TLCO%, and 6MWD) and SpO2, while SP-D correlated with 6MWD and SpO2. In CTD-ILD, KL-6 and SP-D levels were positively correlated with BAL cell count (KL-6: r = 0.58, p = 0.04; SP-D: r = 0.63, and p = 0.02). KL-6 also showed a negative correlation with the time since symptom onset (r = −0.51, p = 0.02). No significant associations were found between the baseline biomarker levels and ILD progression risk. KL-6 and SP-D may serve as potential biomarkers for assessing lung impairment in IPAF, though their predictive value for short-term prognosis remains uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1Lung Diseases, InterstitialPulmonary Surfactant-Associated Protein DLungAutoimmune DiseasesHumansMaleFemaleMiddle AgedBiomarkersAgedRespiratory Function TestsAdultDisease ProgressionTransforming Growth Factor beta1

Stichwörter der Autor:innen

CTDIPAFKL-6SP-DTGF-β1biomarkerconnective tissue diseaseinterstitial pneumonia with autoimmune features

Substanzen

Mucin-1MUC1 protein, humanBiomarkersPulmonary Surfactant-Associated Protein DTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Pneumology, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Pulmonary Rehabilitation, Regional Medical Center for Lung Diseases and Rehabilitation, Blessed Rafal Chylinski Memorial Hospital for Lung Diseases, 91-520 Lodz, Poland.
  • Department of Rheumatology, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.
  • Department of Hematology, Medical University of Lodz, 93-510 Lodz, Poland.
  • Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave, MC 2115, Chicago, IL 60637-1470, USA.

ORCID-Profile: Ewa Miądlikowska, Joanna Miłkowska-Dymanowska, Adam Jerzy Białas, Anna Lewandowska-Polak, Wojciech Jerzy Piotrowski

Förderung

  • Medical University of Lodz

Zitieren

APA

Miądlikowska, E., Miłkowska-Dymanowska, J., Białas, A. J., Makowska, J. S., Lewandowska-Polak, A., Puła, A., Kumor-Kisielewska, A., & Piotrowski, W. J. (2025). Serum KL-6 and SP-D: Markers of Lung Function in Autoimmune-Related Interstitial Lung Diseases. International Journal of Molecular Sciences, 26(3), 1091. https://doi.org/10.3390/ijms26031091

Vancouver

Miądlikowska E, Miłkowska-Dymanowska J, Białas AJ, Makowska JS, Lewandowska-Polak A, Puła A, et al. Serum KL-6 and SP-D: Markers of Lung Function in Autoimmune-Related Interstitial Lung Diseases. International Journal of Molecular Sciences. 2025;26(3):1091. doi:10.3390/ijms26031091

BibTeX
@article{Midlikowska2025,
  author = {Miądlikowska, Ewa and Miłkowska-Dymanowska, Joanna and Białas, Adam Jerzy and Makowska, Joanna Samanta and Lewandowska-Polak, Anna and Puła, Anna and Kumor-Kisielewska, Anna and Piotrowski, Wojciech Jerzy},
  title = {Serum KL-6 and SP-D: Markers of Lung Function in Autoimmune-Related Interstitial Lung Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {1091},
  doi = {10.3390/ijms26031091}
}
Kostenlos starten →